|
Other CYP1A2 substrates
Substrate:
Caffeine Product:
Paraxanthine (and Theobromine
and Theophylline) 
Reference:
Grant, D. et al (1987) Biochem. Pharmacol. 36(8) 1251-1260 Biotransformation
of caffeine by microsomes from human liver. Assayed
in 0.12M potassium phosphate buffer pH7.4 / 2mM MgCl2 / 0.23% KCl
at 37°C
for 15min in 0.5ml final volume. Reaction
stopped by the addition of 10ml chloroform : isopropanol 85 : 15
0.05ml
internal standard solution (0.005mg/ml 7methyl xanthine, 0.005 mg/ml 1,7-dimethyluric
acid in H2O) added, mixture vortexed Saturating
amount ammonium sulphate (~0.5g) added, mixture vortexed and centrifuged. Organic
layer removed and evaporated to dryness under N2. Residue resuspended
in mobile phase. Analysed
by reversed phase HPLC using Beckman Ultrasphere ODS 25cm x 4.6mm column and UV
detection at 273nm. Mobile
phase: isocratic, 0.05% acetic acid : methanol 88 : 12 Substrate:
Ethoxyresorufin Product:
Resorufin Reference:
Grant, M.H. et al (1988) Biochem. Pharmacol. 37(21) 4111-4116
Mixed function oxidase and UDP-glucuronyltransferase activities in the human HEP
G2 hepatoma cell line. Assayed
in 0.1M potassium phosphate buffer pH7.6 at 37°C
in 0.5ml final volume. Reaction
stopped by addition of 0.75ml ice cold acetone. Samples
centrifuged 12000 g for 5min. Fluorescence
of supernatant measured at emission wavelength 600nm and excitation wavelength
580nm Substrate:
Oestradiol Product:
2-hydroxy-oestradiol Reference:
Ball, S. et al (1990) Biochem. J. 267 221-226 Mixed function
oxidase and UDP-glucuronyltransferase activities in the human HEP G2 hepatoma
cell line. Assayed
in 0.02M Tris / HCl buffer pH7.4 at 37°C for 30min in 3ml final volume. Reaction
stopped by addition of 5ml diethyl ether. 4µg
mestranol added as internal standard. Organic
layer removed and evaporated to dryness. Residue
resuspended in mobile phase. Analysed
by reversed phase HPLC using Spherisorb 5-ODS 25cm x 0.46cm column and UV detection
at 280nm. Mobile
phase 0.5% w/v ammonium phosphate pH3 : methanol (ratio not stated) Substrate:
Imipramine Product:
Desipramine Reference:
Koyama, E. et al (1997) J. Pharm. Exp. Ther. 281(3) 1199-1210
Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation:
a study using poor metabolisers of S-mephenytoin and eleven recombinant human
CYPs. Assayed
in 0.1M potassium phosphate buffer pH7.4 / 4mM MgCl2 / 0.1mM EDTA
at 37°C for 30min in 0.25ml final volume. Reaction
stopped by the addition of 100µl cold acetonitrile 10µl
25µM mianserin added as internal standard, 50µl 0.1M potassium phosphate
pH 3.0 added. Reaction
centrifuged. Analysed
by reversed phase HPLC using CAPCELL PAK phenylSG-120 column and UV detection
at 204nm. Mobile
phase: acetonitrile : 0.05M potassium phosphate pH3.0 26 : 74 Substrate:
Clozapine Product:
N-demethylclozapine Reference:
Linnet, K. & Olesen, O.V. (1997) Drug Metab. Dispos. 25(12) 1379-1382
Metabolism of clozapine by cDNA-expressed human cytochrome P450 enzymes. Assayed
in 0.1M potassium phosphate buffer pH7.4 / 4mM MgCl2 / 0.1mM EDTA
at 37°C
for 15min in 0.3ml final volume. Reaction
stopped by the addition of 1ml 0.5M carbonate/bicarbonate pH 10.5. 50µl
6µM (E)-10-hydroxynortriptylline added as internal standard. Extracted
into 5ml heptane : isoamyl alcohol 98.5 : 1.5 Evaporated
to dryness at 60°C under nitrogen. Residue
dissolved in 75µl mobile phase. Analysed
by reversed phase HPLC using Zorbax 300 SB 3µm C18 column and
UV detection at 260nm. Mobile
phase: 0.025M K2HPO4 / 0.01M triethylamine pH 5.5 :
acetonitrile 62 : 38 Substrate:
Lisofylline Product:
Pentoxyfylline Reference:
Lee, S.H. & Slattery, J.T. (1997) Drug Metab. Dispos. 25(12) 1354-1358
Cytochrome P450 isozymes involved in lisofylline metabolism to pentoxifylline
in human liver microsomes. Assayed
in 0.1M potassium phosphate buffer pH7.4 at 37°C
for 10min in 0.5ml final volume. Reaction
stopped by the addition of 6ml methylene chloride. Organic
layer removed and dried under N2. Residue
analysed by reversed phase HPLC using a 3µm C18 column and UV
detection at 273nm. Mobile
phase: 25mM ammonium
phosphate containing 0.25% acetic acid (pH 4.5) : methanol 65 :
35 Substrate:
Riluzole Product:
N-hydroxy riluzole Reference:
Sanderink, G. et al (1997) J. Pharm. Exp. Ther. 282(3) 1465-1472
Involvement of human CYP1A isozymes in the metabolism & drug interactions
of riluzole in vitro. Assayed
in 0.1M potassium phosphate buffer pH7.4, 10mM MgCl2 at 37°C
for up to 20 min. Reaction
stopped by the addition of equal vol. of methanol : acetonitrile 3.6 :
1. Reaction centrifuged. Supernatant
analysed by reversed phase HPLC over Lichrosphere 60 RP Select B 5µm column
and UV detection at 265nm. Mobile
phase: 10mM K2HPO4
: methanol : acetonitrile : glacial acetic acid 108 :
72 : 20 : 1 Important:
By purchasing this product from Cypex you accept the standard terms
and conditions of supply, details of which may be provided upon request.
Adobe®
Acrobat® Reader is software that lets you view and print Portable Document
Format (PDF) files. Acrobat Reader also lets you fill in and submit PDF forms
online. Made
under licence from BTG International Ltd (AU730155, EP0914446, US6566108 and other
patents pending). United States Patent Nos. 5,420,027 or 5,240,831, Canada
Patent No. 2100245 and other patents pending. |